Anisha E. Mendonza

466 total citations
20 papers, 320 citations indexed

About

Anisha E. Mendonza is a scholar working on Transplantation, Molecular Biology and Pharmacology. According to data from OpenAlex, Anisha E. Mendonza has authored 20 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Anisha E. Mendonza's work include Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Diabetes Treatment and Management (4 papers). Anisha E. Mendonza is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Diabetes Treatment and Management (4 papers). Anisha E. Mendonza collaborates with scholars based in United States, Switzerland and India. Anisha E. Mendonza's co-authors include Fatemeh Akhlaghi, Reginald Gohh, Yanling He, William G. Haynes, Shenglin Ma, Tzong‐Huei Lee, Yiming Zhang, Eric Bachman, William A. Chutkow and David E. Holt and has published in prestigious journals such as Circulation, Diabetes and Hypertension.

In The Last Decade

Anisha E. Mendonza

19 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anisha E. Mendonza United States 10 117 84 77 77 73 20 320
Marie‐Noëlle Bizot France 8 61 0.5× 217 2.6× 43 0.6× 52 0.7× 61 0.8× 8 420
Wen-Sheng Guo United States 5 141 1.2× 37 0.4× 66 0.9× 324 4.2× 54 0.7× 5 628
Ching‐Ming Yeh United States 13 37 0.3× 224 2.7× 45 0.6× 43 0.6× 45 0.6× 18 466
Shuichi Fukuen Japan 6 42 0.4× 66 0.8× 27 0.4× 74 1.0× 121 1.7× 6 419
Kazushige Takahashi Japan 10 30 0.3× 34 0.4× 36 0.5× 119 1.5× 110 1.5× 26 400
Paweł K. Kunicki Poland 10 125 1.1× 9 0.1× 94 1.2× 53 0.7× 59 0.8× 26 345
Rosario Calvo Spain 12 50 0.4× 12 0.1× 90 1.2× 128 1.7× 70 1.0× 30 470
C. Davis United States 5 29 0.2× 53 0.6× 27 0.4× 39 0.5× 39 0.5× 7 319
Joelle Campestrini United States 16 91 0.8× 415 4.9× 64 0.8× 96 1.2× 183 2.5× 29 776

Countries citing papers authored by Anisha E. Mendonza

Since Specialization
Citations

This map shows the geographic impact of Anisha E. Mendonza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anisha E. Mendonza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anisha E. Mendonza more than expected).

Fields of papers citing papers by Anisha E. Mendonza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anisha E. Mendonza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anisha E. Mendonza. The network helps show where Anisha E. Mendonza may publish in the future.

Co-authorship network of co-authors of Anisha E. Mendonza

This figure shows the co-authorship network connecting the top 25 collaborators of Anisha E. Mendonza. A scholar is included among the top collaborators of Anisha E. Mendonza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anisha E. Mendonza. Anisha E. Mendonza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanter, Julie, Deepa Manwani, Abdullah Kutlar, et al.. (2024). Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study. Therapeutic Advances in Hematology. 15. 1574210268–1574210268.
2.
Mogi, Muneto, Anisha E. Mendonza, James E. Chastain, et al.. (2023). Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep). Translational Vision Science & Technology. 12(9). 5–5. 7 indexed citations
3.
Heeney, Matthew M., David C. Rees, Mariane de Montalembert, et al.. (2023). S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS STUDY. HemaSphere. 7(S3). e3247294–e3247294. 1 indexed citations
4.
5.
Mendonza, Anisha E., et al.. (2021). Pharmacokinetics, metabolism, and excretion of licogliflozin, a dual inhibitor of SGLT1/2, in rats, dogs, and humans. Xenobiotica. 51(4). 413–426. 7 indexed citations
6.
He, Yanling, et al.. (2020). Investigation and Management of Stool Frequency and Consistency Associated With SGLT1 Inhibition by Reducing Dietary Carbohydrate: A Randomized Trial. Clinical Pharmacology & Therapeutics. 108(5). 995–1002. 4 indexed citations
7.
He, Yanling, William G. Haynes, Charles D. Meyers, et al.. (2019). The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes. Diabetes Obesity and Metabolism. 21(6). 1311–1321. 65 indexed citations
8.
Yi, B. Alexander, Anisha E. Mendonza, Kenneth Kulmatycki, et al.. (2018). Abstract 12892: Safety and Efficacy of LHW090 in Patients With Resistant Hypertension: Results of a Randomized, Double Blind, Parallel Group, Placebo-Controlled Study. Circulation. 1 indexed citations
9.
Haynes, William G., Charles D. Meyers, Anisha E. Mendonza, et al.. (2018). LIK066, a Dual SGLT1/2 Inhibitor, Reduces Weight and Improves Multiple Incretin Hormones in Clinical Proof-of-Concept Studies in Obese Patients With or Without Diabetes. Diabetes. 67(Supplement_1). 3 indexed citations
10.
Mendonza, Anisha E., Imad Hanna, Phillip J. Koo, et al.. (2015). Assessment of pharmacokinetic drug‐drug interaction between pradigastat and atazanavir or probenecid. The Journal of Clinical Pharmacology. 56(3). 355–364. 9 indexed citations
11.
Gan, Lu, Xuemin Jiang, Anisha E. Mendonza, et al.. (2015). Pharmacokinetic drug–drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel‐ethinyl estradiol in healthy subjects. Clinical Pharmacology in Drug Development. 5(1). 27–39. 19 indexed citations
12.
Mendonza, Anisha E., Thomas Langenickel, Therese Swan, et al.. (2013). Abstract 456: Assessment of Pharmacokinetic Drug Interaction between LCZ696 and Metformin. Hypertension. 62(suppl_1). 3 indexed citations
13.
Risinger, Robert, Zubin Bhagwagar, Feng Luo, et al.. (2013). Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study. Psychopharmacology. 231(11). 2299–2310. 13 indexed citations
14.
Sunkara, Gangadhar, Girish Bende, Anisha E. Mendonza, et al.. (2013). Bioavailability of valsartan oral dosage forms. Clinical Pharmacology in Drug Development. 3(2). 132–138. 7 indexed citations
15.
Akhlaghi, Fatemeh, Miroslav Dostálek, Pål Falck, et al.. (2011). The Concentration of Cyclosporine Metabolites Is Significantly Lower in Kidney Transplant Recipients With Diabetes Mellitus. Therapeutic Drug Monitoring. 34(1). 38–45. 28 indexed citations
16.
Mendonza, Anisha E., Reginald Gohh, & Fatemeh Akhlaghi. (2008). Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients. Clinical Pharmacokinetics. 47(11). 733–742. 16 indexed citations
17.
Mendonza, Anisha E., Hamim Zahir, Reginald Gohh, & Fatemeh Akhlaghi. (2007). Tacrolimus in Diabetic Kidney Transplant Recipients: Pharmacokinetics and Application of a Limited Sampling Strategy. Therapeutic Drug Monitoring. 29(4). 391–398. 22 indexed citations
18.
Mendonza, Anisha E., Reginald Gohh, & Fatemeh Akhlaghi. (2006). Analysis of Mycophenolic Acid in Saliva Using Liquid Chromatography Tandem Mass Spectrometry. Therapeutic Drug Monitoring. 28(3). 402–406. 33 indexed citations
19.
Mendonza, Anisha E., Fatemeh Akhlaghi, Oneeb Majid, et al.. (2004). Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. Journal of Chromatography B. 813(1-2). 287–294. 51 indexed citations
20.
Mendonza, Anisha E., Reginald Gohh, & Fatemeh Akhlaghi. (2004). Determination of Cyclosporine in Saliva using Liquid Chromatography???Tandem Mass Spectrometry. Therapeutic Drug Monitoring. 26(5). 569–575. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Noëlle Bizot Breakdown of academic impact, for papers by Wen-Sheng Guo Breakdown of academic impact, for papers by Ching‐Ming Yeh Breakdown of academic impact, for papers by Shuichi Fukuen Breakdown of academic impact, for papers by Kazushige Takahashi Breakdown of academic impact, for papers by Paweł K. Kunicki Breakdown of academic impact, for papers by Rosario Calvo Breakdown of academic impact, for papers by C. Davis Breakdown of academic impact, for papers by Joelle Campestrini
Rankless by CCL
2026